TipRanks
SK Biopharmaceuticals Co., Ltd. (KR:326030)
:326030
South Korea Market
326030
SK Biopharmaceuticals Co., Ltd.
RESEARCH TOOLSreports

SK Biopharmaceuticals Co., Ltd. (326030) Ratios

― Followers

SK Biopharmaceuticals Co., Ltd. Ratios

KR:326030's free cash flow for Q2 2026 was ₩0.93. For the 2026 fiscal year, KR:326030's free cash flow was decreased by ₩ and operating cash flow was ₩0.39. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.72 2.31 1.64 2.02 2.99
Quick Ratio
 2.42 1.97 1.36 1.60 2.43
Cash Ratio
 1.18 1.04 0.81 0.99 0.64
Solvency Ratio
 1.05 0.76 0.56 -0.04 -0.36
Operating Cash Flow Ratio
 0.78 0.61 0.24 -0.39 -0.98
Short-Term Operating Cash Flow Coverage
 27.95 21.42 0.63 -1.88 0.00
Net Current Asset Value
₩ 481.24B₩ 311.19B₩ 188.54B₩ 86.50B₩ 140.24B
Leverage Ratios
Debt-to-Assets Ratio
 0.03 0.04 0.18 0.25 0.23
Debt-to-Equity Ratio
 0.05 0.06 0.34 0.63 0.49
Debt-to-Capital Ratio
 0.05 0.06 0.25 0.39 0.33
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.25 0.31
Financial Leverage Ratio
 1.39 1.47 1.90 2.55 2.10
Debt Service Coverage Ratio
 23.22 20.05 1.58 >-0.01 -33.02
Interest Coverage Ratio
 54.31 26.52 9.02 -2.49 -35.27
Debt to Market Cap
 <0.01 <0.01 0.02 0.02 0.03
Interest Debt Per Share
 694.77 722.88 2.49K 2.38K 2.04K
Net Debt to EBITDA
 -1.40 -1.17 -1.37 7.07 -0.41
Profitability Margins
Gross Profit Margin
91.89%92.21%92.13%90.40%84.66%
EBIT Margin
25.55%28.86%15.21%-6.77%-56.36%
EBITDA Margin
27.40%31.25%18.39%-2.46%-51.09%
Operating Profit Margin
35.20%28.86%17.59%-5.81%-53.24%
Pretax Profit Margin
33.58%21.35%13.26%-12.36%-57.87%
Net Profit Margin
46.55%37.77%43.96%-9.27%-56.64%
Continuous Operations Profit Margin
45.50%35.83%41.45%-9.97%-56.64%
Net Income Per EBT
138.64%176.92%331.61%74.98%97.87%
EBT Per EBIT
95.38%73.99%75.35%212.59%108.69%
Return on Assets (ROA)
28.26%22.28%23.22%-4.55%-20.99%
Return on Equity (ROE)
46.63%32.83%44.07%-11.59%-44.05%
Return on Capital Employed (ROCE)
27.68%22.58%15.04%-4.28%-26.15%
Return on Invested Capital (ROIC)
27.45%22.17%12.07%-3.09%-25.31%
Return on Tangible Assets
29.42%23.27%23.97%-4.66%-21.55%
Earnings Yield
6.76%2.74%2.77%-0.41%-2.49%
Efficiency Ratios
Receivables Turnover
 2.64 2.92 3.11 3.06 3.67
Payables Turnover
 8.97 5.90 12.66 14.53 1.63
Inventory Turnover
 0.73 0.55 0.39 0.33 0.42
Fixed Asset Turnover
 15.01 11.68 12.46 7.43 12.10
Asset Turnover
 0.61 0.59 0.53 0.49 0.37
Working Capital Turnover Ratio
 1.69 2.20 2.18 1.24 0.76
Cash Conversion Cycle
 600.07 727.56 1.03K 1.19K 754.74
Days of Sales Outstanding
 138.23 125.06 117.46 119.15 99.37
Days of Inventory Outstanding
 502.52 664.38 945.76 1.10K 878.67
Days of Payables Outstanding
 40.68 61.88 28.82 25.12 223.30
Operating Cycle
 640.75 789.45 1.06K 1.22K 978.04
Cash Flow Ratios
Operating Cash Flow Per Share
 3.21K 2.31K 1.21K -1.20K -2.04K
Free Cash Flow Per Share
 3.11K 2.22K 1.04K -1.24K -2.12K
CapEx Per Share
 99.91 88.00 171.42 41.49 76.12
Free Cash Flow to Operating Cash Flow
 0.97 0.96 0.86 1.03 1.04
Dividend Paid and CapEx Coverage Ratio
 32.16 26.20 7.07 -28.99 -26.83
Capital Expenditure Coverage Ratio
 32.16 26.20 7.07 -28.99 -26.83
Operating Cash Flow Coverage Ratio
 5.15 3.69 0.51 -0.53 -1.03
Operating Cash Flow to Sales Ratio
 0.29 0.26 0.17 -0.27 -0.65
Free Cash Flow Yield
4.11%1.78%0.94%-1.21%-2.97%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 15.51 36.55 36.22 -245.54 -40.10
Price-to-Sales (P/S) Ratio
 6.97 13.81 15.89 22.75 22.71
Price-to-Book (P/B) Ratio
 5.88 12.00 15.93 28.46 17.66
Price-to-Free Cash Flow (P/FCF) Ratio
 24.64 56.19 106.79 -82.85 -33.71
Price-to-Operating Cash Flow Ratio
 23.87 54.05 91.68 -85.71 -34.96
Price-to-Earnings Growth (PEG) Ratio
 0.30 3.28 -0.04 3.21 0.13
Price-to-Fair Value
 5.88 12.00 15.93 28.46 17.66
Enterprise Value Multiple
 24.05 43.00 85.02 -918.22 -44.87
Enterprise Value
 5.60T 9.50T 8.56T 8.01T 5.64T
EV to EBITDA
 23.72 43.00 85.02 -918.22 -44.87
EV to Sales
 6.50 13.44 15.64 22.58 22.92
EV to Free Cash Flow
 22.96 54.70 105.09 -82.22 -34.02
EV to Operating Cash Flow
 22.25 52.62 90.22 -85.06 -35.29
Tangible Book Value Per Share
 12.34K 9.90K 6.91K 3.87K 3.82K
Shareholders’ Equity Per Share
 13.05K 10.38K 6.98K 3.62K 4.04K
Tax and Other Ratios
Effective Tax Rate
 -0.36 -0.68 -2.13 0.19 0.02
Revenue Per Share
 11.00K 9.02K 6.99K 4.53K 3.14K
Net Income Per Share
 5.12K 3.41K 3.07K -419.89 -1.78K
Tax Burden
 1.39 1.77 3.32 0.75 0.98
Interest Burden
 1.31 0.74 0.87 1.82 1.03
Research & Development to Revenue
 0.16 0.25 0.29 0.39 0.50
SG&A to Revenue
 0.24 0.21 0.21 0.58 0.46
Stock-Based Compensation to Revenue
 <0.01 0.00 0.01 0.00 <0.01
Income Quality
 0.63 0.68 0.42 2.86 1.15
Currency in KRW